-
Spiradenocarcinoma
Study
EGAS00001001799
-
Combined MEK and BCL-2/XL inhibition is effective in high-grade serous ovarian cancer patient-derived xenograft models and BIM levels are predictive of responsiveness
Study
EGAS00001003427
-
Functional Mapping of AKT Signaling and Biomarkers of Response From the FAIRLANE Trial of Neoadjuvant Ipatasertib Plus Paclitaxel for Triple-Negative Breast Cancer
Study
EGAS00001005892
-
Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases
Study
phs003165
-
Genome and gene analysis of gastrointestinal cancer and elucidation of its clinicopathological significance
Study
JGAS000233
-
Histone chaperone CHAF1A promotes proliferation and tumorigenicity in gastric cancer and impacts prognosis via context-depedent regulation of gene expression
Study
EGAS00001003064
-
The ICGC-TCGA DREAM Somatic Mutation Calling - Tumour Heterogeneity Challenge
Study
EGAS00001002092
-
Somatic_mutation_profiling_of_intestinal_crypts_from_IBD
Study
EGAS00001002896
-
Molecular origins of mpMRI visibility
Study
EGAS00001003179
-
Genetic_mechanisms_of_resistance_to_chemotherapy_in_breast_cancer
Study
EGAS00001000276